Loading…
Medical Affairs Strategic Summit Virtual has ended
Simple
Expanded
Grid
By Venue
Wednesday, May 5
 

11:00am EDT

Am I doing this right?: An Industry Workshop on Compliance
The Pharmaceutical Industry has an ethical obligation to provide fair-balanced scientific information and education about their products, not only to the health care community but to the patients receiving the treatments. PhRMA guidelines provide the guardrails that ensure all are operating with integrity and upholding high ethical standards. There are company variations regarding compliance guidelines, however, at their core, compliant methodologies and guidances are consistent across the pharmaceutical industry.

This workshop will provide discussions on Medical Science Liaison, Manager, Headquarter, and Commercial interactions; and will include a review of the guidelines across the product lifecycle. Understanding compliance is not straightforward, but knowing the basics will provide confidence in performing daily activities. During small breakouts, you will have the opportunity to discuss scenarios in a safe space with industry peers and learn to be more comfortable when talking about and asking questions about compliance.
Speakers
avatar for Jaclyn Quilantan

Jaclyn Quilantan

Medical Science Liaison, Kala Pharmaceuticals
Jaclyn is a Medical Science Liaison at Kala Pharmaceuticals. She completed her B.S. in Biology from St. Mary’s University in San Antonio, and her Ph.D. in Biomedical Sciences from the University of North Texas Health Science Center in Fort Worth. After completing her Ph.D. she assumed... Read More →
avatar for Howard L. Dorfman

Howard L. Dorfman

Adjunct Professor, Seton Hall University School of Law
Howard L. Dorfman is Founder of H.L. Dorfman Pharmaceutical Consulting, LLC, which provides compliance, regulatory, and risk management consulting services to pharmaceutical and biotech companies and law firms. In addition, he is an Adjunct Professor and Distinguished Practitioner... Read More →
avatar for Davida J. White, MD

Davida J. White, MD

Lead, Global Field Medical Excellence and Operations, Organon (Merck)
Davida J. White, M.D. is a health care leader with administrative and clinical experience in the government, academic, biopharmaceutical and medical device industry settings.  She currently is the Oncology Field Alignment Medical Affairs Director for Merck.  Prior to joining Merck... Read More →

Wednesday May 5, 2021 11:00am - 1:30pm EDT
Zoom Room
  Workshop 1

2:30pm EDT

Re-Emerging from The Pandemic Workshop: How to Make the Most Impact in a Hybrid World & How to Navigate 2021
The COVID-19 pandemic has impacted patients, healthcare providers, and the pharmaceutical industry. Medical Affairs organizations have had to radically rethink how to deliver scientific engagement over the past year. As we emerge from a year of virtual interactions, how should we be planning for the future? Will we return to the pre-pandemic model, or are there lessons to be learned from our pandemic-era innovations? Join your Medical Affairs colleagues for a discussion of these issues with a focus on identifying value-add solutions and innovations.
Speakers
avatar for Ina Shah, PharmD, BCMAS

Ina Shah, PharmD, BCMAS

Executive Director Medical Information, AbbVie
Ina Shah is currently the Executive Director, Global Medical Information at AbbVie. In this role, she is leading a global team that develops medical content and supports medical inquiries from customers. Prior to this, she has held various positions at Hoffmann LaRoche in clinical... Read More →
avatar for Deborah Long, MD

Deborah Long, MD

Senior Vice President, Medical Affairs, Vertex Pharmaceuticals
Deborah is the  Senior Vice President for Global Medical Affairs at Vertex Pharmaceuticals, where she has been since 2017. Prior to this, Deborah held various leadership roles in medical affairs, including leading the US Medical Affairs COPD team at GSK, and the Americas Internal... Read More →
avatar for Arthur Chan, Ph.D., MBA

Arthur Chan, Ph.D., MBA

Vice President Medical Affairs, Tarsus Pharmaceuticals, Inc.
Arthur Chan, Ph.D., MBA, is an innovative and creative medical affairs leader with over 18 years of experience in various therapeutic areas. He’s a biomedical engineer by training with expertise in medical device and pharmaceuticals focused in eyecare. Arthur is the Vice President... Read More →

Wednesday May 5, 2021 2:30pm - 5:00pm EDT
Zoom Room
  Workshop 2
 
Thursday, May 6
 

10:00am EDT

Chairperson’s Opening Remarks
Speakers
avatar for Carol Hoang Roller, PharmD, MBA

Carol Hoang Roller, PharmD, MBA

VP Medical Affairs, Adverum Biotechnologies
Carol Hoang Roller is a pharmaceutical and healthcare executive with experience across multiple sectors of the healthcare industry including biotech, pharmaceutical, managed care, specialty distribution, digital health and gene therapy.  Experience includes domestic and international... Read More →

Thursday May 6, 2021 10:00am - 10:10am EDT
  Considerations for Medical Affairs Leadership

10:10am EDT

Keynote: COVID-19 Pandemic: Challenges of Leadership
  • Review how medical affairs leaders are leading through a changing environment and supporting their teams. Discuss changes in the day-to-day and the vision for the future. 
  • What your organization is doing specifically in launching new therapies virtually, and what persists.
  • Discuss the most important leadership skills needed for COVID and post- COVID environments.
Speakers
avatar for Kirk Shepard

Kirk Shepard

Chief Medical Officer & SVP, Head of Global Medical Affairs OBG, Eisai, Inc.
Dr. Kirk Shepard is a board-certified medical oncologist and hematologist physician. He is currently CMO and Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Inc. Pharmaceutical Company.  Dr. Shepard’s experience in multiple therapeutic areas includes diverse... Read More →

Thursday May 6, 2021 10:10am - 10:40am EDT
  Considerations for Medical Affairs Leadership

10:45am EDT

How to Ensure your Team is Emerging Successfully from the Pandemic
  • Discuss the emergence out of the pandemic, providing lessons learned, and what successful teams are doing differently from others
  • Focus on the different skill sets needed to ensure optimal function in this new environment and tackling these complexities
  • Dive into the activities most impacted by COVID
  • Discuss tactics used to keep team engaged, healthy (physically and mentally), and safe

Moderators
avatar for Barbara Troupin, MD, MBA

Barbara Troupin, MD, MBA

Recent Senior Vice President, Medical Affairs, MyoKardia (acquired by BMS)
Dr. Troupin has 20+ years of pharmaceutical industry C-suite leadership experience as a CMO leading Medical Affairs, Clinical Development, and Regulatory Affairs in small, private and publicly traded pharmaceutical companies. Her most recent role was Senior Vice President Medical... Read More →

Speakers
avatar for Lee Ding, PharmD

Lee Ding, PharmD

Senior Director, Managed Care Liaison of RWE/HEOR, MyoKardia
Lee Ding, PharmD, is a Senior Director, Field Health Economic Outcome Research, at MyoKardia/BMS. Lee has over 25 years of biopharmaceutical and managed care experiences in a variety of settings, such as Genentech/Roche, BlueCross BlueShield health plan and health system. In... Read More →
avatar for Alan Polnariev, PharmD, MS

Alan Polnariev, PharmD, MS

Senior Medical Science Liaison, U.S. Medical Affairs, Renal Therapeutic Area, AstraZeneca
Dr. Alan Polnariev is dedicated to providing value in healthcare by ensuring that the right patient receives the right medication for the right reasons.   As a board-certified pharmacist with clinical, academic and industry experience, Dr. Polnariev commits... Read More →
avatar for Cathy Andorfer, Ph.D.

Cathy Andorfer, Ph.D.

US Field Medical Dermatology Lead, Bristol Myers Squibb
avatar for Tom Pulles, MD

Tom Pulles, MD

Vice President, Head of Medical Affairs & Patient Advocacy, EMEA, Ultragenyx
Tom has almost 20 years of experience in the Pharmaceutical and Biotech Industry. After working in the Royal Netherlands Navy, he held different medical functions in industry, including a privately owned company developing high quality medical education.Since 2011 he lives in Switzerland... Read More →

Thursday May 6, 2021 10:45am - 11:30am EDT
  Considerations for Medical Affairs Leadership

11:35am EDT

Engaging Key Stakeholders via Compliant Virtual Technology
  • Top Medical Affairs trends that will shape how virtual engagement is used post-pandemic
  • The various methods of virtual interaction: real-time, anytime, and hybrid model
  • Real-world case studies of successful virtual work in action
  • What the pace of innovation in virtual interaction means for Medical Affairs teams in the future
Speakers
avatar for Amy Pinelli

Amy Pinelli

Regional Vice President, Business Partnerships, Within3
With more than 23 years of experience in the life sciences industry, Amy partners with medical, clinical and commercial teams to enhance their communication with outside stakeholders. Her leadership in strategic planning, revenue generation, and business consultation has established... Read More →
avatar for Petra Loesch

Petra Loesch

Director Medical Affairs, BeiGene
Petra Loesch, M.S., is a Director of Global Medical Affairs with BeiGene where she focuses on Key Opinion Leader Engagement, Compliance and Patient Advocacy. She closely partners with the Field Medical Team in engagement with external collaborators and thought leaders. . Petra... Read More →

Thursday May 6, 2021 11:35am - 12:05pm EDT
  Considerations for Medical Affairs Leadership

12:05pm EDT

“Meet the Speakers” Zoom Party hosted by Within3
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with the MASS Speaking Faculty and attendees in this zoom breakout room!
Thursday May 6, 2021 12:05pm - 12:35pm EDT
Zoom Room
  Considerations for Medical Affairs Leadership

12:35pm EDT

Observations and Insights: Where do I go from here?
  • What is an insight?
  • Gathering and reporting insights
  • Taking action and following up
  • Company resources and limitations
Speakers
avatar for Brant Jarrett

Brant Jarrett

Executive Director, Head of Medical Affairs, Mallinckrodt Pharmaceuticals
Brant Jarrett is the Executive Director of Field Medical Affairs at Mallinckrodt Pharmaceuticals. He entered Pharma as an MSL and has had various leadership positions in Medical Affairs including Regional Director, National Director, Medical Director, and Sr. Director Field... Read More →

Thursday May 6, 2021 12:35pm - 1:05pm EDT
  Considerations for Medical Affairs Leadership

1:10pm EDT

Making the Case – How Does Medical Affairs Matter?
  • Review the data needed to measure impact, quantifying value of in-person visits, and measuring productivity; making the case to enter back into the field
  • Discuss what type of support worked best for in-house and field teams
  • How to recognize when people are not doing well in this new environment
Moderators
avatar for Susan Malecha, PharmD, MBA

Susan Malecha, PharmD, MBA

Sr. Director, Medical Affairs, Puma Biotechnology
As an accomplished author, Susan Malecha has lectured extensively and is called upon to present the latest developments in the areas of medical affairs for the pharmaceutical industry. Dr. Malecha is an active member of Healthcare Businesswomen’s Association (HBA), as the current... Read More →

Speakers
avatar for Susan Abedi

Susan Abedi

Executive Vice President, Strategy and Insights, 81QD
Susan has more than 20 years of experience developing medical and commercial strategies, building multi-stakeholder value propositions, and improving HCP engagement. As Executive Vice President of Strategy & Insights at 81qd, Susan focuses on developing robust, analytics-driven solutions... Read More →
avatar for Scott McConnell, Pharm.D.

Scott McConnell, Pharm.D.

Vice President Medical Affairs, Chiasma
Scott McConnell, Pharm.D. is currently the VP of Medical Affairs at Chiasma. He has spent the last 15 years in various roles within Medical Affairs at Cubist, Merck, Chiasma and Alkermes. Prior to industry he spent several years in both academic and clinical pharmacy positions... Read More →
avatar for Stacey Curtiss, Pharm.D.

Stacey Curtiss, Pharm.D.

Vice President, Medical Affairs, REGENXBIO Inc.
Stacey is Vice President of Medical Affairs at REGENXBIO. She has over 15 years’ experience in Medical Affairs across large and emerging biotech, gene therapy and digital therapeutics companies supporting Neuroscience, Ophthalmology and Rare Disease therapeutic areas. Prior to... Read More →
avatar for April Adams

April Adams

Sr. Director, Field Medical – Cardiovascular, Bristol Myers Squibb
April Adams is a focused and strategically driven leader in Medical Affairs with over 20 years of experience in the pharmaceutical industry. Her background includes being an MSL, an MSL Regional Director, and Global Director for Field Medical Excellence.  During her career she... Read More →

Thursday May 6, 2021 1:10pm - 1:55pm EDT
  Considerations for Medical Affairs Leadership

2:00pm EDT

The Role of Field Medical in Supporting Diversity Initiatives in Clinical Development
  • Share how a field medical team evolved to emphasize the importance of diversity in clinical trials with clinical trial sites and primary investigators
  • Understand how to leverage external ecosystems and internal partnerships to incorporate diversity and inclusion in medical affairs
  • Review innovative approaches to enhance the engagement and knowledge of the field medical team on diversity in clinical research
Speakers
avatar for Christina Wright

Christina Wright

Senior Regional Medical Science Liaison, Bristol Myers-Squibb
Christina Wright is a Senior Medical Science Liaison at Bristol Myers Squibb (BMS). She obtained her Doctor of Pharmacy from the Florida A&M University College of Pharmacy in 2011. Following graduation, she completed a pharmacy industry fellowship at BMS in Medical Information. Over... Read More →

Thursday May 6, 2021 2:00pm - 2:30pm EDT
  Considerations for Medical Affairs Leadership

2:35pm EDT

“Meet the Speakers” Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with the MASS Speaking Faculty and attendees in this zoom breakout room!
Thursday May 6, 2021 2:35pm - 3:05pm EDT
Zoom Room
  Roundtable Discussion
 
Friday, May 7
 

10:00am EDT

Chairperson’s Opening Remarks
Speakers
avatar for Arthur Chan, Ph.D., MBA

Arthur Chan, Ph.D., MBA

Vice President Medical Affairs, Tarsus Pharmaceuticals, Inc.
Arthur Chan, Ph.D., MBA, is an innovative and creative medical affairs leader with over 18 years of experience in various therapeutic areas. He’s a biomedical engineer by training with expertise in medical device and pharmaceuticals focused in eyecare. Arthur is the Vice President... Read More →

Friday May 7, 2021 10:00am - 10:10am EDT
  Digital Transformation of Medical Affairs

10:10am EDT

Keynote: Deep Dive into the Current Medical Affairs Landscape
  • People, process, product - what has changed for Medical Affairs?
  • Which capabilities should we prioritize for effective Digital engagements?
  • Learn the pros and cons of Digital approaches
Speakers
avatar for Eddie G M Power, PhD MBA GFMD

Eddie G M Power, PhD MBA GFMD

Vice President, North America Medical Affairs, Hospital Business Unit, Pfizer Biopharmaceuticals Group
Eddie Power PhD MBA is currently the VP, North America Medical Affairs, Hospital Business at Pfizer and has held positions of increasing responsibility during his career in the pharmaceutical industry.He started at Pfizer in September 2010 leading US teams in Vaccines and Infectious... Read More →

Friday May 7, 2021 10:10am - 10:40am EDT
  Digital Transformation of Medical Affairs

10:45am EDT

What Capabilities do Medical Affairs Colleagues Need to Develop in a Pandemic/Post-Pandemic Environment
  • Evaluate ways to optimize communication with HPCs, payers and patient groups in the current environment and visualize needs in our future state.
  • Evaluate ways to optimize communication with cross functional internal colleagues in the current environment and visualize needs in our future state.
  • Explore ways to maximize the team’s skill sets and digital solutions to enhance overall capabilities and identify any gaps.
Moderators
avatar for Eva Gallagher, PhD, RN, ANP-BC

Eva Gallagher, PhD, RN, ANP-BC

Vice President, Head of Medical Affairs, Agios Pharmaceuticals
Currently serving as Vice President, Head of Global Medical Affairs at Agios Pharmaceuticals, Eva reports to the Chief Medical Officer. In this role she is responsible for oversight of Scientific Communications, Publications, Medical Information, Health Economics Outcomes Research... Read More →

Speakers
avatar for Brett Balzer

Brett Balzer

Practice Director, Medical Affairs, Mavens, A Komodo Health Company
Brett has been responsible for the strategic direction, growth, and customer success of Mavens’ medical affairs practice for the past 8 years. He has collaborated on dozens of implementations across MI contact centers, Medical portals, safety solutions, and mobile tools. Brett has... Read More →
avatar for Ruth du Moulin, Ph.D.

Ruth du Moulin, Ph.D.

Vice President, Medical Affairs, Forma Therapeutics, Inc
Ruth is a recognized medical affairs executive with global and US experience in small and large biotech/pharmaceutical companies both in pre-commercial and commercial settings where responsibilities span informing pipeline decisions to leading successful product launches - primarily... Read More →
avatar for Alan Wright, MD, MPH

Alan Wright, MD, MPH

Chief Medical Officer, Roche Diagnostics
As the Chief Scientific Officer for Roche Diagnostics Corporation, Dr. Wright serves as its lead clinical and policy spokesperson on all aspects of clinical diagnostic medicine. As a physician with extensive background in the managed care, pharmaceutical, clinical laboratory, and... Read More →
avatar for Jill Fenwick PhD

Jill Fenwick PhD

Director, Medical Excellence & Training, Oncology, US Medical Affairs, EMD Serono
Ph.D. in Lung Cancer. 20 years in the pharmaceutical industry in the UK before moving to the USA. Worked as an MSL, European MSL (responsible for several countries including the UK), and MSL manager.Launched multiple therapies as an MSL, as a European MSL, and in UK and Ireland as... Read More →

Friday May 7, 2021 10:45am - 11:30am EDT
  Digital Transformation of Medical Affairs

11:35am EDT

Executive Interview: Bruno Larvol, CEO and Founder, LARVOL
Speakers
avatar for Bruno Larvol

Bruno Larvol

CEO and Founder, LARVOL
As founder and CEO of LARVOL, Bruno leads a global and completely remote team providing intelligence reports and data solutions to the world’s leading pharmaceutical and life science teams. Prior to LARVOL, he founded several technology and healthcare ventures. He has worked previously... Read More →

Friday May 7, 2021 11:35am - 11:50am EDT
  Digital Transformation of Medical Affairs

11:50am EDT

Networking Break
Friday May 7, 2021 11:50am - 12:35pm EDT
  Digital Transformation of Medical Affairs

12:35pm EDT

Digital Innovation in Medical Affairs - Bigger, Sharper and Far More Personalized
  • Understand how the medical affairs function is evolving to meet the needs of healthcare providers and their patients
  • Review actionable, innovative, and data-driven tactics to enhance the value proposition of medical affairs
  • Learn how to leverage AI and data for a more effective and efficient approach to field medical operations
Speakers
avatar for Andrew Rosen, PhD

Andrew Rosen, PhD

Director of Global Data Generation, Ionis Pharmaceuticals
A new digital revolution is emerging in the biopharma industry, and Andrew Rosen is leaning in with a wealth of innovative tools and tactics. Andrew is Director of Global Data Generation at Akcea Therapeutics. He is applying digital health transformation to streamline clinical... Read More →

Friday May 7, 2021 12:35pm - 1:05pm EDT
  Digital Transformation of Medical Affairs

1:10pm EDT

Running Virtually: From AdBoards to Launch Support
COVID has necessitated Medical Affairs adapt to virtual over the traditional in-person engagement. While there have been pluses to the switch to virtual conferences, ad boards, product launches, and 1:1 KOL interactions, there have also been some challenges. This discussion will: 
  • Share best practices for ensuring a rich and productive engagement in the virtual world;
  • Recreate the same activities as live events in a virtual platform
  • Discuss how to incorporate interactive collaboration tools that approximate live engagement amongst peers.
Moderators
avatar for Daniel Snyder, Ph.D.

Daniel Snyder, Ph.D.

Vice President, Medical Affairs, Urovant Sciences, Inc
Daniel Snyder, PhD is Vice President, Medical Affairs at Urovant Sciences in Irvine, CA. Daniel has been in the pharmaceutical/biologics/medical device space 28 years post doctorate; the first 12 years of his career were in R&D, and the past 16 years have been in Medical Affairs... Read More →

Speakers
avatar for Robert Groebel

Robert Groebel

VP of Global Medical Strategy, Monocl
Robert Groebel is the VP of Global Medical Strategy at Monocl. He is recognized for his ability to create a strategic vision and accelerate innovation via technology. He has more than 25 years of healthcare experience holding global medical and commercial roles at both Boehringer... Read More →
avatar for Kanchan Relwani, M.D.

Kanchan Relwani, M.D.

Senior Vice President, Head of Medical Affairs, Alkermes
Kanchan Relwani M.D. serves as Alkermes’ Senior Vice President of Medical Affairs. Dr. Relwani leads the Medical Affairs organization, including oversight of the Medical Strategy, Medical Operations & Alliances, Heath Economics and Outcomes Research, Medical Information and Medical... Read More →
avatar for Mark Wildgust, Ph.D.

Mark Wildgust, Ph.D.

Vice President, Global Medical Affairs, Oncology, Janssen
Mark Wildgust has spent more than 20 years in the pharmaceutical industry working primarily in oncology, hematology and virology. He completed his undergraduate degree in Biological Sciences at the University of Plymouth, UK, and his PhD in Trace Metal Toxicology at the University... Read More →
avatar for Karen Veverka, Ph.D.

Karen Veverka, Ph.D.

Vice President, Medical, ASLAN Pharmaceuticals
Karen Veverka, Ph.D. is Vice President of US Medical at ASLAN Pharmaceuticals. She has >20 years with biotech and biopharmaceutical companies previously serving as Senior Medical Director at LEO Pharma Inc., Regional Scientific Director at Novartis, and Director of Preclinical Development... Read More →

Friday May 7, 2021 1:10pm - 1:55pm EDT
  Digital Transformation of Medical Affairs

2:00pm EDT

“Meet the Speakers” Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with the MASS Speaking Faculty and attendees in this zoom breakout room!
Friday May 7, 2021 2:00pm - 2:45pm EDT
Zoom Room
  Digital Transformation of Medical Affairs
 
Filter sessions
Apply filters to sessions.
Wednesday, May 5
Thursday, May 6
Friday, May 7
Zoom Room
  • Considerations for Medical Affairs Leadership
  • Digital Transformation of Medical Affairs
  • Roundtable Discussion
  • Workshop 1
  • Workshop 2
  • Popular